FMR CORP 13D/13G Filings for Acceleron Pharma Inc. (XLRN)

FMR CORP 13D and 13G filings for Acceleron Pharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-11-10
12:24 pm
Sale		 2021-11-09 13G Acceleron Pharma Inc.
XLRN		 FMR CORP 493,493
0.807%		 -4,184,920decrease
(-89.45%)		 Filing
2021-02-08
10:15 am
Sale		 2021-02-05 13G Acceleron Pharma Inc.
XLRN		 FMR CORP 4,678,413
7.764%		 -1,208,250decrease
(-20.53%)		 Filing
2020-09-10
10:03 am
Sale		 2020-09-09 13G Acceleron Pharma Inc.
XLRN		 FMR CORP 5,886,663
9.828%		 -2,075,571decrease
(-26.07%)		 Filing